C
Edwards Lifesciences Corporation EW
$81.07 -$0.76-0.93% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -9.04% 1.73% 4.24% 697.82% 19.28%
Total Depreciation and Amortization -3.79% -4.94% 16.08% -6.50% 9.70%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1,048.94% -27.52% -71.80% -181,000.00% 87.37%
Change in Net Operating Assets -581.20% 73.15% -114.30% 5,703.28% 89.37%
Cash from Operations -21.88% 624.11% -193.34% -14.51% 1,005.65%
Capital Expenditure 42.27% 14.24% 43.60% 6.15% -78.29%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -748.26% -- --
Divestitures -- -- -- -- --
Other Investing Activities -158.42% 10.05% -505.50% -384.27% 77.98%
Cash from Investing -237.90% 35.18% -4,190.07% 2,935.62% 77.78%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 87.29% -19.65% -13.86% 1.47% -10.69%
Repurchase of Common Stock -- -154,200.00% 99.98% -473.97% -2,008.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -780.56% 450.00% -95.00% -251.72% 700.00%
Cash from Financing 154.55% -518.15% 106.92% -581.58% -285.41%
Foreign Exchange rate Adjustments -200.68% -282.47% 1,600.00% -659.78% 93.42%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -67.09% 11.11% -134.90% 452.76% 150.79%